Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity.
10.26599/1671-5411.2025.05.006
- Author:
Mei ZHANG
1
;
Dian-Fu LI
2
;
Jun PU
3
Author Information
1. Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
2. Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University/Jiangsu Province Hospital, Nanjing, China.
3. Department of Cardiology, Renji Hospital, State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Collective Name:Chinese Anti-Cancer Association Society of Integrative Cardio-oncology, Ultrasound Branch of the Chinese Medical Association, Chinese Society of Echocardiography
- Publication Type:Journal Article
- From:
Journal of Geriatric Cardiology
2025;22(5):477-496
- CountryChina
- Language:English
-
Abstract:
Cardiovascular damage caused by cancer treatment has become an important cause of death for tumor survivors. With the recognition of cardiovascular diseases and cancer therapy-related cardiovascular toxicity (CTR-CVT) in tumor patients, noninvasive imaging technologies play pivotal roles in the risk stratification, early diagnosis, monitoring and follow-up for CTR-CVT. In recent years, the field of cardio-oncology has witnessed continual updates in diagnostic and therapeutic strategies, with several pertinent guidelines and expert consensus documents issued in China and abroad. However, there remains a conspicuous absence of systematic guidance documents on the application of imaging techniques in the clinical practice of cardio-oncology. Therefore, the Chinese Anti-Cancer Association Society of Integrative Cardio-oncology, the Ultrasound Branch of the Chinese Medical Association, and the Chinese Society of Echocardiography convened experts to formulate the "Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity". Building upon the systematic evaluation of guidelines and the latest evidence-based medical research in the field of cardio-oncology domestically and abroad, and in conjunction with data derived from evidence-based medical research in China, this guideline proposes noninvasive imaging examination methods and monitoring strategies for CTR-CVT, aiming to further standardize and guide the clinical practice of multidisciplinary physicians specializing in cardio-oncology in China.
